Value Investing, Videos

Bill Ackman Talks To Congress About Valeant

Published on Apr 27, 2016

April 27 — Bill Ackman, Pershing Square Capital Management’s chief executive officer, speaks at a Senate hearing on Valeant and drug pricing. Pershing Square has investments in Valeant.

SCA_Pearson_4_27_16

SCA_Ackman_4_27_16

SCA_Schiller_4_27_16

More here

AckmanSenate

Get our newsletter and our in-depth investor case studies all for free!